Tuesday, January 02, 2018 11:36:11 AM
SOURCE: https://www.dailymarijuanaobserver.com/single-post/2018/01/02/DIGP-Digipath-Announces-Record-Fiscal-Year-Results-for-2017
Digipath Announces Record Fiscal Year Results for 2017
January 2, 2018
|
PR Newswire
LAS VEGAS, Jan. 2, 2018 /PRNewswire/ -- Digipath, Inc. (OTC:DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing cannabis market, today announced financial and operating results for the fiscal year ended September 30, 2017.
Ended fiscal year debt free with $380,189 of working capital, including $178,177 of cash on hand
Annual sales were $1,898,172, an increase of 132% on a year-over-year basis
Fourth quarter sales of $602,057 increased by 74% over the third quarter, and by 93% vs. the fourth quarter of 2016, as Nevada recreational cannabis sales commenced in July 2017, resulting in another record quarter
Reduced our net loss by 71% over the comparative net loss in 2016
Adjusted EBITDA for the year was $(375,377), compared to Adjusted EBITDA of $(949,946) for the previous fiscal year, an improvement of approximately 60% on a year-over-year basis
REST OF ARTICLE: https://www.dailymarijuanaobserver.com/single-post/2018/01/02/DIGP-Digipath-Announces-Record-Fiscal-Year-Results-for-2017
Recent DIGP News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 04:57:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 03:41:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:27:03 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/16/2024 10:17:16 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 07:28:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 06:18:09 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 07:33:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM